tirzepatide cardiovascular outcomes trial 2024 reduces the predicted risk of atherosclerotic disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT‐1 post hoc analysis - Hankosky - Tirzepatide as Compared with Semaglutide
Description
Many people move from three meals plus snacks to two larger meals or several small meals throughout the day
Track appetite changes subjectively on a 1-10 scale
Move Daily: Aim for 30 minutes of walking, cycling, or at-home workouts most days
It remains investigational, with approval not expected before late 2027
The list price for Victoza is $815 for a 3-pen package
